Molecular Mechanisms of Alzheimer's Biomarker FDDNP Binding to Aβ Amyloid Fibril

被引:14
|
作者
Parikh, Niyati D. [1 ]
Klimov, Dmitri K. [1 ]
机构
[1] George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA
来源
JOURNAL OF PHYSICAL CHEMISTRY B | 2015年 / 119卷 / 35期
关键词
DYNAMICS SIMULATIONS; IBUPROFEN BINDING; IMAGING PROBE; THIOFLAVIN-T; IN-VITRO; PEPTIDE; DISEASE; BRAIN; IDENTIFICATION; PLAQUES;
D O I
10.1021/acs.jpcb.5b06112
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Using isobaric-isothermal replica exchange molecular dynamics and the all-atom explicit water model, we examined the binding of FDDNP biomarkers to the A beta amyloid fibril fragment. Our results can be summarized as follows. First, FDDNP ligands bind with high affinity to the A beta fibril, and the hydrophobic effect together with pi-stacking interactions are the dominant factors governing FDDNP binding. In comparison, electrostatic interactions and hydrogen bonding play a minor role. Second, our simulations reveal a strong tendency of bound FDDNP molecules for self-aggregation. Accordingly, about two-thirds of all bound ligands form aggregated clusters of various sizes, and ligand-ligand interactions make considerable contribution to FDDNP binding. Third, FDDNP ligands bind to two distinct sites on the A beta fibril. Primary binding sites (NT) are located at the N-terminals of A beta 10-40 peptides, whereas secondary ones (CE) occur on the concave fibril edge near fibril channels. The NT sites are characterized by strong hydrophobic and pi-stacking interactions, favorable binding entropy resulting from multiple FDDNP binding orientations and propensity for self-aggregation but relatively weak van der Waals interactions. In contrast, the CE sites offer stronger van der Waals binding interactions but weaker hydrophobic and aromatic interactions and less favorable binding entropy. By comparing our data with previous studies, we suggest that the primary binding locations identified by us are likely to occur in other A beta fibril polymorphic structures. We also show that FDDNP binds via distinct mechanisms to A beta fibrils and monomers. We argue that FDDNP binds with stronger affinity to benign A beta monomers than to the fibrils, raising questions about the ability of FDDNP to selectively label amyloid deposits.
引用
收藏
页码:11568 / 11580
页数:13
相关论文
共 50 条
  • [1] Binding of FDDNP Biomarker to Alzheimer's Disease Aβ Peptide
    Lockhart, Christopher
    Klimov, Dmitri K.
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 360A - 360A
  • [2] Molecular Interactions of Alzheimer's Biomarker FDDNP with Aβ Peptide
    Lockhart, Christopher
    Klimov, Dmitri K.
    BIOPHYSICAL JOURNAL, 2012, 103 (11) : 2341 - 2351
  • [3] Molecular mechanisms initiating amyloid β-fibril formation in Alzheimer's disease
    Kirkitadze, MD
    Kowalska, A
    ACTA BIOCHIMICA POLONICA, 2005, 52 (02) : 417 - 423
  • [4] Binding of cystatin C to Alzheimer's amyloid β inhibits in vitro amyloid fibril formation
    Sastre, M
    Calero, M
    Pawlik, M
    Mathews, PM
    Kumar, A
    Danilov, V
    Schmidt, SD
    Nixon, RA
    Frangione, B
    Levy, E
    NEUROBIOLOGY OF AGING, 2004, 25 (08) : 1033 - 1043
  • [5] Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease
    Drolle, Elizabeth
    Hane, Francis
    Lee, Brenda
    Leonenko, Zoya
    DRUG METABOLISM REVIEWS, 2014, 46 (02) : 207 - 223
  • [6] Structure and morphology of the Alzheimer's amyloid fibril
    Stromer, T
    Serpell, LC
    MICROSCOPY RESEARCH AND TECHNIQUE, 2005, 67 (3-4) : 210 - 217
  • [7] A molecular model of Alzheimer amyloid β-peptide fibril formation
    Tjernberg, LO
    Callaway, DJE
    Tjernberg, A
    Hahne, S
    Lilliehöök, C
    Terenius, L
    Thyberg, J
    Nordstedt, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) : 12619 - 12625
  • [8] Molecular mechanisms underlying initiation of amyloid fibril formation
    Yanagisawa, K
    NEUROSCIENTIFIC BASIS OF DEMENTIA, 2001, : 241 - 247
  • [9] Amyloid fibril toxicity in Alzheimer's disease and diabetes
    Lorenzo, A
    Yankner, BA
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 89 - 95
  • [10] Progress in molecular mechanisms of β-amyloid peptides in Alzheimer's disease
    Sun Li-Wen
    Tang Syao-Wei
    Hu Ying-He
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2007, 34 (01) : 18 - 24